Stock screener

ARQT

Conviction 80HealthcareScan · Mon, Jul 20, 2026
ARQT$27.52-3.40%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
2
2
5
Vol MA14 1.58M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Arcutis Biotherapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.arcutis.com ↗
Price27.52
Change-3.40%
Gap+0.60%
Rel volume1.69×
Avg volume1.72M
Avg $ vol46.92M
SMA 2027.14
SMA 5024.10
SMA 20024.98
Price vs 50+14.17%
Price vs 200+10.18%
MA stackmixed
50/200 cross—
Supertrendup · 25.46
RSI (14)57
MACD hist-0.09
MACD crossbear · 5d
Stoch %K / %D49 / 58
ADX (14)37
+DI / −DI30 / 14
RSI divergenceBearish
MACD divergenceBearish
ATR %+4.54%
ADR %4.52%
52w high31.20
52w low14.12
From 52w high-11.79%
Above 52w low+94.90%
New 52w highNo
SqueezeOff
Bollinger width12.71%
%B0.61
Donchian pos49.46%
Donchian high29.84
Donchian low25.25
AVWAP (52w high)25.19
vs AVWAP high+9.25%
AVWAP (52w low)23.74
vs AVWAP low+15.94%
OBV trendFlat
Chaikin MF (20)0.01
Today vs 20d1.69×
Avg vol (14d)1.58M
Avg vol (20d)1.72M
Avg $ vol (20d)46.92M
Market cap3.44B
RS 3m (vs SPY)+11.84%
RS 6m (vs SPY)-1.08%
RS line new highYes
Trend template7/8
Technical rank74.2
1 week+1.47%
1 month+4.96%
3 months+12.19%
6 months+4.40%
1 year+77.78%
YTD-5.10%
P/E-213.26
P/B18.15
P/S9.15
P/FCF-545.44
EPS-0.1300
Div yield—
ROE-8.51%
ROA-3.51%
Debt/Eq0.58
Current2.68
EV/EBITDA—
Gross margin—
Net margin-4.29%
Rev growth91.34%
EPS growth88.47%
Price target34.86
Target upside26.67%
Analyst ratingBuy
Institutional112.39%
Ent. value3.52B
Revenue105.4M
Net income-11.29M
Gross profit—
Free cash flow-6.31M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.08M
Employees354
ListedFri, Jan 31, 2020
Free float109.34M
Float %89.3%
Short interest14.02M
Days to cover6.3d
Short volume39.9%
Squeeze score61 / 100
Next earningsWed, Aug 5, 2026 · after (16d)
EPS forecast$0.07 · 2 est
Last EPS vs est−$0.09 vs −$0.02
Last surprise-350.0% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank74.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance29.11
Support20.74
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARQT · 1 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-29
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in ARQT · 6 buys · 4 sells

InsiderSideShares
Welgus Howard G.
Director · Common Stock · 2026-07-15
Exercise1.02K
Welgus Howard G.
Director · Common Stock · 2026-07-15
Sell4.73K
Welgus Howard G.
Director · Stock Option (right to buy) · 2026-07-15
Exercise822
Welgus Howard G.
Director · Common Stock · 2026-07-15
Exercise2.25K
Welgus Howard G.
Director · Stock Option (right to buy) · 2026-07-15
Exercise1.02K
Welgus Howard G.
Director · Stock Option (right to buy) · 2026-07-15
Exercise2.25K
Peetz Christopher
Director · Common Stock · 2026-07-15
Grant4.32K
Welgus Howard G.
Director · Common Stock · 2026-07-15
Exercise822
Peetz Christopher
Director · Stock Option (right to buy) · 2026-07-15
Grant21.49K
Peetz Christopher
Director · Stock Option (right to buy) · 2026-07-15
Grant13.01K

SEC filings

EDGAR filings in ARQT · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.